Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-6-22
pubmed:abstractText
Streptococcus pneumoniae is the most common pathogen associated with otitis media. To examine the role of Toll-like receptor 2 (TLR2) in host defense against Streptococcus pneumoniae infection in the middle ear, wild-type (WT; C57BL/6) and TLR2-deficient (TLR2(-/-)) mice were inoculated with Streptococcus pneumoniae (1 x 10(6) CFU) through the tympanic membrane. Nineteen of 37 TLR2(-/-) mice showed bacteremia and died within 3 days after the challenge, compared to only 4 of 32 WT mice that died. Of those that survived, more severe hearing loss in the TLR2(-/-) mice than in the WT mice was indicated by an elevation in auditory-evoked brain stem response thresholds at 3 or 7 days postinoculation. The histological pathology was characterized by effusion and tissue damage in the middle ear, and in the TLR2(-/-) mice, the outcome of infection became more severe at 7 days. At both 3 and 7 days postchallenge, the TLR2(-/-) mice had higher blood bacterial titers than the WT mice (P < 0.05), and typical bacteria were identified in the effusion from both ears of both mouse groups by acridine orange staining. Moreover, by 3 days postchallenge, the mRNA accumulation levels of NF-kappaB, tumor necrosis factor alpha, interleukin 1beta, MIP1alpha, Muc5ac, and Muc5b were significantly lower in the ears of TLR2(-/-) mice than in WT mice. In summary, TLR2(-/-) mice may produce relatively low levels of proinflammatory cytokines following pneumococcal challenge, thus hindering the clearance of bacteria from the middle ear and leading to sepsis and a high mortality rate. This study provides evidence that TLR2 is important in the molecular pathogenesis and host response to otitis media.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-10191216, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-10320101, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-10384090, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-10549626, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-10722599, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-10764016, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-10888929, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-11035751, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-11067888, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-11350794, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-11751980, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-12194982, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-12198614, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-12242135, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-12496429, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-14616553, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-14690596, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-14695318, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-15210557, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-15215247, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-15546996, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-15879155, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-16137770, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-16164030, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-16299338, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-16495516, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-16497588, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-16540890, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-16887307, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-17059694, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-17359235, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-17611057, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-17693552, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-18063379, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-18091336, http://linkedlifedata.com/resource/pubmed/commentcorrection/19414550-18549453
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1098-5522
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3100-8
pubmed:dateRevised
2010-9-27
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Role for Toll-like receptor 2 in the immune response to Streptococcus pneumoniae infection in mouse otitis media.
pubmed:affiliation
Department of Otolaryngology-HNS, Case Western Reserve University, Cleveland, Ohio 44106, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural